Blocking IL-6 or IL-6R did not decrease viability nor migration of the cancer cells, whereas inhibiting macrophage migration inhibitory factor (MIF) did decrease tumor cell migration, but not viability. The gene discussed is IL6R; the disease is neoplasm.